These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15851820)

  • 1. Are estrogens protective or risk factors in brain injury and neurodegeneration? Reevaluation after the Women's health initiative.
    Wise PM; Dubal DB; Rau SW; Brown CM; Suzuki S
    Endocr Rev; 2005 May; 26(3):308-12. PubMed ID: 15851820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen therapy: does it help or hurt the adult and aging brain? Insights derived from animal models.
    Wise PM
    Neuroscience; 2006; 138(3):831-5. PubMed ID: 16310320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of neuroprotection by estrogen.
    Suzuki S; Brown CM; Wise PM
    Endocrine; 2006 Apr; 29(2):209-15. PubMed ID: 16785597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minireview: neuroprotective effects of estrogen-new insights into mechanisms of action.
    Wise PM; Dubal DB; Wilson ME; Rau SW; Böttner M
    Endocrinology; 2001 Mar; 142(3):969-73. PubMed ID: 11181507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens and cerebrovascular stroke: what do animal models teach us?
    Wise PM
    Ann N Y Acad Sci; 2005 Jun; 1052():225-32. PubMed ID: 16024765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and the brain: beyond ER-alpha, ER-beta, and 17beta-estradiol.
    Toran-Allerand CD
    Ann N Y Acad Sci; 2005 Jun; 1052():136-44. PubMed ID: 16024756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models.
    Sohrabji F
    Ann N Y Acad Sci; 2005 Jun; 1052():75-90. PubMed ID: 16024752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile.
    Zhao L; O'Neill K; Brinton RD
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1124-32. PubMed ID: 16951259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens, estrogen receptors, and female cognitive aging: the impact of timing.
    Daniel JM
    Horm Behav; 2013 Feb; 63(2):231-7. PubMed ID: 22587940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens, brain, and behavior: lessons from knockout mouse models.
    Hill RA; Boon WC
    Semin Reprod Med; 2009 May; 27(3):218-28. PubMed ID: 19401953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of estradiol in middle-aged female rats.
    Dubal DB; Wise PM
    Endocrinology; 2001 Jan; 142(1):43-8. PubMed ID: 11145565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the estrogen in neuroprotection: implications for neurodegenerative diseases.
    Cho JJ; Iannucci FA; Fraile M; Franco J; Alesius TN; Stefano GB
    Neuro Endocrinol Lett; 2003; 24(3-4):141-7. PubMed ID: 14523347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
    Gleason CE; Carlsson CM; Johnson S; Atwood C; Asthana S
    Ann N Y Acad Sci; 2005 Jun; 1052():93-115. PubMed ID: 16024754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of a novel selective estrogen receptor modulator with an estrogen protects the mammary gland and uterus in a rodent model: the future of postmenopausal women's health?
    Labrie F; El-Alfy M; Berger L; Labrie C; Martel C; Bélanger A; Candas B; Pelletier G
    Endocrinology; 2003 Nov; 144(11):4700-6. PubMed ID: 12960051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17beta-estradiol activates ICI 182,780-sensitive estrogen receptors and cyclic GMP-dependent thioredoxin expression for neuroprotection.
    Lee SY; Andoh T; Murphy DL; Chiueh CC
    FASEB J; 2003 May; 17(8):947-8. PubMed ID: 12626428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death.
    Dubal DB; Rau SW; Shughrue PJ; Zhu H; Yu J; Cashion AB; Suzuki S; Gerhold LM; Bottner MB; Dubal SB; Merchanthaler I; Kindy MS; Wise PM
    Endocrinology; 2006 Jun; 147(6):3076-84. PubMed ID: 16527848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.